Zenith Capital is trading at 1.0E-4 as of the 20th of March 2025. This is a 99.9% down since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Zenith Capital has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company was incorporated in 2013 and is headquartered in Calgary, Canada. More on Zenith Capital Corp
Zenith Capital Corp [ZHCLF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zenith Capital's market, we take the total number of its shares issued and multiply it by Zenith Capital's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zenith Capital Corp classifies itself under Healthcare sector and is part of Biotechnology industry.
Zenith Capital Corp has accumulated about 19 K in cash with (847 K) of positive cash flow from operations.
Check Zenith Capital Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Zenith Capital without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Analyst Advice Now
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Other Information on Investing in Zenith Pink Sheet
Zenith Capital financial ratios help investors to determine whether Zenith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenith with respect to the benefits of owning Zenith Capital security.